|
Volumn 54, Issue 12, 2001, Pages 1111-1115
|
NK30424A and B, novel inhibitors of lipopolysaccharide-induced tumour necrosis factor alpha production, produced by Streptomyces sp. NA30424
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
BACTERIUM LIPOPOLYSACCHARIDE;
BETA GALACTOSIDASE;
GLUTARIMIDE DERIVATIVE;
I KAPPA B ALPHA;
I KAPPA B KINASE;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
LIPOPOLYSACCHARIDE;
NEOMYCIN;
NK 30424A;
NK 30424B;
PROTEIN INHIBITOR;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
UNCLASSIFIED DRUG;
ANIMAL CELL;
CANCER;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
CYTOTOXICITY TEST;
DRUG CONFORMATION;
DRUG EFFECT;
DRUG ISOLATION;
DRUG SYNTHESIS;
FERMENTATION;
LETTER;
MALE;
MOUSE;
MULTIPLE SCLEROSIS;
NONHUMAN;
PERITONEAL EXUDATE CELL;
PERITONITIS;
PRIORITY JOURNAL;
PROMOTER REGION;
RHEUMATOID ARTHRITIS;
SIGNAL TRANSDUCTION;
STEREOISOMERISM;
STREPTOMYCES;
STRUCTURE ACTIVITY RELATION;
TARGET CELL DESTRUCTION;
STREPTOMYCES;
|
EID: 0035700576
PISSN: 00218820
EISSN: None
Source Type: Journal
DOI: 10.7164/antibiotics.54.1111 Document Type: Letter |
Times cited : (17)
|
References (5)
|